YSP Bisocor 5mg Tab

Manufacturer
Y.S.P. Industries (M) Sdn. Bhd.

Registraction Number
MAL16075026AZ



Content (Active Ingredient)

• Each tablet contains Bisoprolol Fumarate 5 /mg as the active ingredient.
• Excipients include lactose monohydrate, microcrystalline cellulose, dicalcium phosphate, crospovidone, colloidal silicon dioxide, magnesium stearate, polyvinyl alcohol, xanthan gum, lecithin, polyethylene glycol, talc, titanium dioxide, and tartrazine (a dye)

• Hypertension (high blood pressure)
• Chronic stable angina pectoris (chest pain)
• Moderate-to-severe chronic heart failure with reduced left ventricular function

• Begin with 5 /mg once daily, taken in the morning, with or without food.
• If blood pressure or angina is not controlled, the dose may increase to 10 /mg once daily, with a maximum of 20 /mg daily.

• Titrate gradually:
  • Week /1: 1.25 /mg once daily
  • Week /2: 2.5 /mg once daily
  • Week /3: 3.75 /mg once daily
  • Weeks /4–7: 5 /mg once daily
  • Weeks /8–11: 7.5 /mg once daily
  • Week /12 and beyond: maintain at 10 /mg once daily
  • Maximum dose in heart failure is 10 /mg daily

• Take Bisocor in the morning, at the same time each day, swallowed whole with water—do not chew or crush.
• It may be taken with food or on an empty stomach.

• Use caution in patients with severe renal impairment (creatinine clearance < /20 /mL/min) or severe liver impairment —do not exceed 10 /mg daily.
• No dose adjustments generally required for elderly or mild-to-moderate renal/hepatic impairment

• Do not stop treatment abruptly, especially if there is ischemic heart disease—gradually taper the dose (e.g. weekly halving) to avoid rebound effects